Recall: D-0377-2021
Class II - Potentially Harmful
Class IIClassification
2021-04-26Initiated
TerminatedStatus
Teva Pharmaceuticals USAFirm
Product
Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial, Rx Only, TEVA Parenteral Medicines, Inc. Irvine, CA 92618 NDC 0703-4502-04
Reason
Lack of Assurance of Sterility
Distribution
Product was distributed nationwide.
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.